Cargando…
Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells
Inflammation and dysfunction of endothelial cells are thought to be triggers for the secretion of Von Willebrand factor. The aim of this study was to examine the effects of the inflammatory cytokines interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-α) and the coagulat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069411/ https://www.ncbi.nlm.nih.gov/pubmed/27766025 http://dx.doi.org/10.7150/ijms.15688 |
_version_ | 1782460931404464128 |
---|---|
author | Meiring, Muriel Allers, W. Le Roux, E. |
author_facet | Meiring, Muriel Allers, W. Le Roux, E. |
author_sort | Meiring, Muriel |
collection | PubMed |
description | Inflammation and dysfunction of endothelial cells are thought to be triggers for the secretion of Von Willebrand factor. The aim of this study was to examine the effects of the inflammatory cytokines interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-α) and the coagulation factors, tissue factor and thrombin on the release and cleavage potential of ultra-large von Willebrand factor (ULVWF) and its cleavage protease by cultured human umbilical vein endothelial cells (HUVEC). HUVEC were treated with IL-6, IL-8, and TNF-α, tissue factor (TF) and thrombin, and combinations thereof for 24 hours under static conditions. The cells were then exposed to shear stress after which the VWF-propeptide levels and the VWF cleavage protease, ADAMTS13 content were measured. All treatments and their combinations, excluding IL-6, significantly stimulated the secretion of VWF from HUVEC. The VWF secretion from the HUVEC was stimulated most by the combination of TF with TNF-α. Slightly lower levels of ADAMTS13 secretion were found with all treatments. This may explain the thrombogenicity of patients with inflammation where extremely high VWF levels and slightly lower ADAMTS13 levels are present. |
format | Online Article Text |
id | pubmed-5069411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-50694112016-10-20 Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells Meiring, Muriel Allers, W. Le Roux, E. Int J Med Sci Research Paper Inflammation and dysfunction of endothelial cells are thought to be triggers for the secretion of Von Willebrand factor. The aim of this study was to examine the effects of the inflammatory cytokines interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-α) and the coagulation factors, tissue factor and thrombin on the release and cleavage potential of ultra-large von Willebrand factor (ULVWF) and its cleavage protease by cultured human umbilical vein endothelial cells (HUVEC). HUVEC were treated with IL-6, IL-8, and TNF-α, tissue factor (TF) and thrombin, and combinations thereof for 24 hours under static conditions. The cells were then exposed to shear stress after which the VWF-propeptide levels and the VWF cleavage protease, ADAMTS13 content were measured. All treatments and their combinations, excluding IL-6, significantly stimulated the secretion of VWF from HUVEC. The VWF secretion from the HUVEC was stimulated most by the combination of TF with TNF-α. Slightly lower levels of ADAMTS13 secretion were found with all treatments. This may explain the thrombogenicity of patients with inflammation where extremely high VWF levels and slightly lower ADAMTS13 levels are present. Ivyspring International Publisher 2016-09-20 /pmc/articles/PMC5069411/ /pubmed/27766025 http://dx.doi.org/10.7150/ijms.15688 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. |
spellingShingle | Research Paper Meiring, Muriel Allers, W. Le Roux, E. Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
title | Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
title_full | Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
title_fullStr | Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
title_full_unstemmed | Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
title_short | Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells |
title_sort | tissue factor: a potent stimulator of von willebrand factor synthesis by human umbilical vein endothelial cells |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069411/ https://www.ncbi.nlm.nih.gov/pubmed/27766025 http://dx.doi.org/10.7150/ijms.15688 |
work_keys_str_mv | AT meiringmuriel tissuefactorapotentstimulatorofvonwillebrandfactorsynthesisbyhumanumbilicalveinendothelialcells AT allersw tissuefactorapotentstimulatorofvonwillebrandfactorsynthesisbyhumanumbilicalveinendothelialcells AT lerouxe tissuefactorapotentstimulatorofvonwillebrandfactorsynthesisbyhumanumbilicalveinendothelialcells |